129 related articles for article (PubMed ID: 35136485)
21. Sorafenib/regorafenib and lapatinib interact to kill CNS tumor cells.
Hamed HA; Tavallai S; Grant S; Poklepovic A; Dent P
J Cell Physiol; 2015 Jan; 230(1):131-9. PubMed ID: 24911215
[TBL] [Abstract][Full Text] [Related]
22. Rationally Repurposing Ruxolitinib (Jakafi (®)) as a Solid Tumor Therapeutic.
Tavallai M; Booth L; Roberts JL; Poklepovic A; Dent P
Front Oncol; 2016; 6():142. PubMed ID: 27379204
[TBL] [Abstract][Full Text] [Related]
23. (Curcumin+sildenafil) enhances the efficacy of 5FU and anti-PD1 therapies in vivo.
Dent P; Booth L; Roberts JL; Poklepovic A; Hancock JF
J Cell Physiol; 2020 Oct; 235(10):6862-6874. PubMed ID: 31985048
[TBL] [Abstract][Full Text] [Related]
24. Role of AMPK/mTOR-independent autophagy in clear cell renal cell carcinoma.
Radovanovic M; Vidicevic S; Tasic J; Tomonjic N; Stanojevic Z; Nikic P; Vuksanovic A; Dzamic Z; Bumbasirevic U; Isakovic A; Trajkovic V
J Investig Med; 2020 Dec; 68(8):1386-1393. PubMed ID: 33087428
[TBL] [Abstract][Full Text] [Related]
25. Mechanisms of GZ17-6.02 resistance.
Booth L; West C; Von Hoff D; Dent P
Anticancer Drugs; 2022 Jun; 33(5):415-423. PubMed ID: 35276694
[TBL] [Abstract][Full Text] [Related]
26. Neratinib augments the lethality of [regorafenib + sildenafil].
Booth L; Roberts JL; Rais R; Cutler RE; Diala I; Lalani AS; Hancock JF; Poklepovic A; Dent P
J Cell Physiol; 2019 Apr; 234(4):4874-4887. PubMed ID: 30203445
[TBL] [Abstract][Full Text] [Related]
27. Valproate augments Niraparib killing of tumor cells.
Booth L; Roberts JL; Rais R; Poklepovic A; Dent P
Cancer Biol Ther; 2018; 19(9):797-808. PubMed ID: 29923797
[TBL] [Abstract][Full Text] [Related]
28. BCL-2 family inhibitors enhance histone deacetylase inhibitor and sorafenib lethality via autophagy and overcome blockade of the extrinsic pathway to facilitate killing.
Martin AP; Park MA; Mitchell C; Walker T; Rahmani M; Thorburn A; Häussinger D; Reinehr R; Grant S; Dent P
Mol Pharmacol; 2009 Aug; 76(2):327-41. PubMed ID: 19483105
[TBL] [Abstract][Full Text] [Related]
29. The Lethality of [Pazopanib + HDAC Inhibitors] Is Enhanced by Neratinib.
Booth L; Roberts JL; Poklepovic A; Dent P
Front Oncol; 2019; 9():650. PubMed ID: 31380285
[TBL] [Abstract][Full Text] [Related]
30. A novel combination of isovanillin, curcumin, and harmine (GZ17-6.02) enhances cell death and alters signaling in actinic keratoses cells when compared to individual components and two-component combinations.
Bordeaux ZA; Kwatra SG; Booth L; Dent P
Anticancer Drugs; 2023 Apr; 34(4):544-550. PubMed ID: 36847046
[TBL] [Abstract][Full Text] [Related]
31. PDE5 inhibitors enhance the lethality of pemetrexed through inhibition of multiple chaperone proteins and via the actions of cyclic GMP and nitric oxide.
Booth L; Roberts JL; Poklepovic A; Gordon S; Dent P
Oncotarget; 2017 Jan; 8(1):1449-1468. PubMed ID: 27903966
[TBL] [Abstract][Full Text] [Related]
32. PDE5 inhibitors enhance celecoxib killing in multiple tumor types.
Booth L; Roberts JL; Cruickshanks N; Tavallai S; Webb T; Samuel P; Conley A; Binion B; Young HF; Poklepovic A; Spiegel S; Dent P
J Cell Physiol; 2015 May; 230(5):1115-27. PubMed ID: 25303541
[TBL] [Abstract][Full Text] [Related]
33. Phosphodiesterase 5 inhibitors enhance chemotherapy killing in gastrointestinal/genitourinary cancer cells.
Booth L; Roberts JL; Cruickshanks N; Conley A; Durrant DE; Das A; Fisher PB; Kukreja RC; Grant S; Poklepovic A; Dent P
Mol Pharmacol; 2014 Mar; 85(3):408-19. PubMed ID: 24353313
[TBL] [Abstract][Full Text] [Related]
34. Neratinib decreases pro-survival responses of [sorafenib + vorinostat] in pancreatic cancer.
Booth L; Poklepovic A; Dent P
Biochem Pharmacol; 2020 Aug; 178():114067. PubMed ID: 32504550
[TBL] [Abstract][Full Text] [Related]
35. ADIPOQ/adiponectin induces cytotoxic autophagy in breast cancer cells through STK11/LKB1-mediated activation of the AMPK-ULK1 axis.
Chung SJ; Nagaraju GP; Nagalingam A; Muniraj N; Kuppusamy P; Walker A; Woo J; Győrffy B; Gabrielson E; Saxena NK; Sharma D
Autophagy; 2017 Aug; 13(8):1386-1403. PubMed ID: 28696138
[TBL] [Abstract][Full Text] [Related]
36. The levels of mutant K-RAS and mutant N-RAS are rapidly reduced in a Beclin1 / ATG5 -dependent fashion by the irreversible ERBB1/2/4 inhibitor neratinib.
Booth L; Roberts JL; Poklepovic A; Kirkwood J; Sander C; Avogadri-Connors F; Cutler RE; Lalani AS; Dent P
Cancer Biol Ther; 2018 Feb; 19(2):132-137. PubMed ID: 29219657
[TBL] [Abstract][Full Text] [Related]
37. [pemetrexed + sildenafil], via autophagy-dependent HDAC downregulation, enhances the immunotherapy response of NSCLC cells.
Booth L; Roberts JL; Poklepovic A; Dent P
Cancer Biol Ther; 2017 Sep; 18(9):705-714. PubMed ID: 28812434
[TBL] [Abstract][Full Text] [Related]
38. Curcumin interacts with sildenafil to kill GI tumor cells via endoplasmic reticulum stress and reactive oxygen/ nitrogen species.
Roberts JL; Poklepovic A; Booth L
Oncotarget; 2017 Nov; 8(59):99451-99469. PubMed ID: 29245915
[TBL] [Abstract][Full Text] [Related]
39. Antagonistic effects of chloroquine on autophagy occurrence potentiate the anticancer effects of everolimus on renal cancer cells.
Grimaldi A; Santini D; Zappavigna S; Lombardi A; Misso G; Boccellino M; Desiderio V; Vitiello PP; Di Lorenzo G; Zoccoli A; Pantano F; Caraglia M
Cancer Biol Ther; 2015; 16(4):567-79. PubMed ID: 25866016
[TBL] [Abstract][Full Text] [Related]
40. AMPK Inhibits ULK1-Dependent Autophagosome Formation and Lysosomal Acidification via Distinct Mechanisms.
Nwadike C; Williamson LE; Gallagher LE; Guan JL; Chan EYW
Mol Cell Biol; 2018 May; 38(10):. PubMed ID: 29507183
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]